Fig. 6

Comparison of ENU-related risk scores across clinical subgroups. (A) Comparison of risk scores between normal and tumor tissues. (B) Stratification of risk scores among different histological types. (C) Risk scores by WHO grade, showing an increasing trend from Grade 2 to Grade 3 and from Grade 3 to Grade 4. (D) Comparison of risk scores between IDH wild-type (WT) and mutant (Mut) status. (E) Age-based comparison of risk scores. (F) Comparison of risk scores between patients who are alive versus dead at last follow-up. * for p < 0.05, ** for p < 0.01, and *** for p < 0.001, with all comparisons conducted using the Wilcoxon rank sum test. The y-axis for all panels represents the risk score